Biocryst Pharmaceuticals Inc recorded an increase in cost of sales by 37.24 % year on year, relative to one quarter ago cost of sales fell by -28.58 % in Q2.
Biocryst Pharmaceuticals Inc recorded increase in cost of sales by 37.24 % year on year, compare to one quarter ago cost of sales fell by -28.58 % in Q2.
Biocryst Pharmaceuticals Inc's Comment on Supply Chain
The company depends on third-party collaborators for multiple stages of product candidate development, including natural protein discovery, preclinical studies, clinical trial management, toxicology studies, formulation improvements, manufacturing of starting materials and drug substances, provision of cell banks or cell line technologies, and regulatory interactions outside the United States. Failure to establish effective collaborations in these areas may adversely affect the business. Risks include insufficient or unavailable raw materials or product candidates at acceptable costs, supply interruptions, development delays or changes, increased costs, and regulatory compliance issues. These risks may be heightened by global health epidemics such as COVID-19.
Biocryst Pharmaceuticals Inc's Comment on Supply Chain
The company depends on third-party collaborators for multiple stages of product candidate development, including natural protein discovery, preclinical studies, clinical trial management, toxicology studies, formulation improvements, manufacturing of starting materials and drug substances, provision of cell banks or cell line technologies, and regulatory interactions outside the United States. Failure to establish effective collaborations in these areas may adversely affect the business. Risks include insufficient or unavailable raw materials or product candidates at acceptable costs, supply interruptions, development delays or changes, increased costs, and regulatory compliance issues. These risks may be heightened by global health epidemics such as COVID-19.
Sources:
Biocryst Pharmaceuticals Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Biocryst Pharmaceuticals Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
